Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03644550
Brief Title: Anti-Mesothelin Immunotoxin LMB-100 Followed by Pembrolizumab in Malignant Mesothelioma

First Submitted : August 22, 2018
First Submitted that Met QC Criteria : August 22, 2018
First Posted : August 23, 2018

Last Update Submitted that Met QC Criteria : March 13, 2021
Last Update Posted : March 16, 2021